MindMaze Therapeutics Holding SA SEC filings MMTZF
MindMaze Therapeutics Holding SA has 60 filings in SEC EDGAR's recent list, going back to Mar 30, 2021. Its latest annual report, Form 20-F, was filed on Apr 30, 2024 for the period ended Dec 31, 2023. The most recent current report (Form 6-K) was filed on Dec 16, 2024. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F | Annual report (foreign issuer) | Apr 30, 2024 | Dec 31, 2023 |
| 20-F | Annual report (foreign issuer) | May 12, 2023 | Dec 31, 2022 |
Showing 2 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MMTZF (OTC), RLFTY (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Switzerland
- Headquarters
- Ch-1202 Geneva
- SEC filer status
- Non-accelerated filer, Emerging growth company
- SEC CIK
- 1854078
- Former names
- Relief Therapeutics Holding SA (until Mar 27, 2025); Relief Therapeutics Holding AG (until Mar 30, 2021)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.